Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
164
-
Total 13F shares, excl. options
-
13,082,269
-
Shares change
-
+570,467
-
Total reported value, excl. options
-
$3,095,022,572
-
Value change
-
+$44,360,145
-
Put/Call ratio
-
247%
-
Number of buys
-
109
-
Number of sells
-
-94
-
Price
-
$236.63
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q2 2014
237 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q2 2014.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 164 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13,082,269 shares
.
Largest 10 shareholders include FMR LLC (3,171,948 shares), ORBIMED ADVISORS LLC (1,656,258 shares), JENNISON ASSOCIATES LLC (1,427,118 shares), Carmignac Gestion (1,000,576 shares), Capital World Investors (736,800 shares), VANGUARD GROUP INC (650,073 shares), PRICE T ROWE ASSOCIATES INC /MD/ (622,030 shares), BlackRock Institutional Trust Company, N.A. (299,364 shares), Viking Global Investors LP (208,077 shares), and LORD, ABBETT & CO. LLC (204,635 shares).
This table shows the top 164 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.